The Future of GLP-1 Therapies: Hype, Evidence, and the Expanding Role of Pharmacists In an interview with Pharmacy Times at the Consortium of Multiple Sclerosis Centers 2026, Donald Langan, PharmD, MD, a Multiple Sclerosis and Clinical Neuroimmunology Fellow at Columbia University, presenting on the evolution of GLP-1 receptor agonists, discussed the future of GLP-1 therapies and the expansion of the pharmacist's role
And, finally, while glutathione is safe for many people, the effectiveness of glutathione therapy can vary based on your individual health, delivery method, and dosage
Therefore, in this study, we hypothesize that Ex-4 is neuroprotective by reducing BBB damage of EBI through downregulation of downstream targets, NF-B and MMP-9 via phosphorylation of AMPK (p-AMPK) after experimental SAH model in rats
Oral contraceptives, which interfere with B6 metabolism, have also been associated with low levels
A Local Team That Cares: Were proud to serve the entire state of Louisiana with the warmth and hospitality you expect from a local provider